[조사 보고서] 세계의 비침습적 산전 검사 (NIPT) 시장 (2024-2030) : 임신 기간별, 임신 위험별, 방법별, 기술별, 제품별, 용도별, 최종 용도별, 지역별

■ 영문 제목 : Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JNU068 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 12월 ■ 페이지수 : 100 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 비침습적 산전 검사 (NIPT) 시장의 성장과 동향
Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 비침습적 산전 검사 (NIPT) 시장 규모는 2030년까지 81.6억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 10.06%의 CAGR을 기록할 것으로 전망됩니다. 염색체 이상 발생률의 증가는 시장 성장을 가속화할 것으로 예상됩니다. 모든 국가 중 중국은 연간 출생아 수가 1465만 명에 육박하고 고위험 임신이 증가하면서 비침습적 산전 검사 (NIPT)에 대한 큰 기회를 가지고 있습니다.

여러 연구에 따르면, 인도에서는 신생아 166명당 1명꼴로 염색체 이상이 발견되며, 삼염색체 21번(다운증후군)은 800명당 1명꼴로 매년 32,000명의 다운증후군 신생아가 태어나는 것으로 나타났습니다. 아기의 유전적 문제를 알 수 있습니다. 따라서 이러한 높은 발생률은 산전 검사에 대한 수요를 증가시킬 것으로 예상됩니다.

코로나19로 인한 봉쇄령에 따라 NIPT가 주목받고 있습니다. 융모막 융모 샘플링이나 양수 천자와 같은 침습적 시술에 비해 감염 위험을 최소화하면서 높은 정확도의 선별검사를 제공할 수 있기 때문입니다. 또한, NIPT 처방에 대한 수요가 증가하고 있지만, 대부분의 국가에서는 인프라가 미비하고 원격 의료 시설이 도입되지 않아 대상자 수가 제한적입니다.

비침습적 산전 검사 (NIPT)에 대한 상환 시나리오는 매우 다양합니다. 그러나 정부의 지원과 유리한 보험 정책이 시장 성장을 견인하고 있습니다. 예를 들어, 네덜란드에서는 임신 2기부터 산전 검사 비용이 전액 환급됩니다. 이로 인해 이러한 검사의 채택이 증가하고 있습니다. 인도, 중국 등 신흥국에서 바이오 및 제약 산업을 장려하는 정부 이니셔티브가 증가함에 따라 비침습적 산전 검사 솔루션 및 서비스에 대한 수요가 증가할 것으로 예상됩니다.

시장의 주요 기업들은 제품 포트폴리오를 강화하고 고객에게 혁신적인 제품을 제공하기 위해 신제품 개발에 주력하고 있으며, 2020년 3월 애질런트 테크놀로지(Agilent Technology)는 세포유전학 연구소의 산전 및 산후 연구를 지원하는 새로운 마이크로어레이 3종을 출시했습니다. 이 세포 마이크로어레이의 프로브는 체질적 DNA 샘플에서 신경정신질환, 발달지연, 지적장애, 선천성 기형과 관련된 복사수 돌연변이 및 복사중립 이형접합성 손실을 높은 해상도로 검출합니다.

비침습적 산전 검사 (NIPT) 시장 보고서 하이라이트

- 임신 기간별로는 임신 후기에 시행됩니다. 비침습적 산전 검사 건수가 가장 많은 13~24주가 2023년 시장을 주도할 것으로 전망됩니다.

- 저위험 임신 위험 부문은 예측 기간 동안 큰 성장을 보일 것으로 예상됩니다. 평균 위험 임신에 대한 예산 배정 등 정부 지원으로 이 부문 성장에 기여합니다.

- 제품별로는 산모 혈장 무세포 DNA 검사 부문이 2023년 가장 큰 매출 점유율을 차지했습니다. 무세포 DNA는 다양한 유전자 분석을 통해 산전 관리에서 유전성 질환의 위험을 예측하는 데 점점 더 많이 활용되고 있습니다.

- 예측 기간 동안 아시아 태평양 지역이 가장 높은 CAGR을 보일 것으로 예상됩니다. 산모 연령의 증가와 의료 인프라의 개선이 시장 성장을 강화할 것으로 보입니다.

- 북미는 높은 R&D 투자, 첨단 의료 시설의 존재, 전장 유전체 염기서열 분석의 발전으로 2023년 시장에서 우위를 점할 것으로 예상됩니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 비침습적 산전 검사 (NIPT) 시장 변수, 트렌드 및 범위
4. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 임신 기간별 비즈니스 분석
5. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 임신 위험별 비즈니스 분석
6. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 방법별 비즈니스 분석
7. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 기술별 비즈니스 분석
8. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 제품별 비즈니스 분석
9. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 용도별 비즈니스 분석
10. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 최종 용도별 비즈니스 분석
11. 세계의 비침습적 산전 검사 (NIPT) 시장 규모 : 지역별 비즈니스 분석
12. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective – 1
1.2.2. Objective – 2
1.2.3. Objective – 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Increasing average maternal age and rising incidence of chromosomal syndromes
3.4.2. High demand for early and noninvasive fetal testing procedure
3.4.3. Improvements in the reimbursement scenario
3.4.4. Rising collaborations and licensing agreements
3.5. Market Restraint Analysis
3.5.1. Ethical concerns with respect to reproductive genetics
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Gestation Period Business Analysis
4.1. Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis
4.2. 0-12 Weeks
4.2.1. 0-12 Weeks Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
4.3. 13-24 Weeks
4.3.1. 13-24 Weeks Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
4.4. 25-36 Weeks
4.4.1. 25-36 Weeks Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
Chapter 5. Pregnancy Risk Business Analysis
5.1. Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis
5.2. High & Average Risk
5.2.1. High & Average Risk Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
5.3. Low Risk
5.3.1. Low Risk Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
Chapter 6. Method Risk Business Analysis
6.1. Non-Invasive Prenatal Testing Market: Method Movement Analysis
6.2. Ultrasound Detection
6.2.1. Ultrasound Detection Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
6.3. Biochemical Screening Tests
6.3.1. Biochemical Screening Tests Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
6.4. Cell-free DNA in Maternal Plasma Tests
6.4.1. Cell-free DNA in Maternal Plasma Tests Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
Chapter 7. Technology Risk Business Analysis
7.1. Non-Invasive Prenatal Testing Market: Technology Movement Analysis
7.2. NGS
7.2.1. NGS Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
7.3. Array Technology
7.3.1. Array Technology Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
7.4. PCR
7.4.1. PCR Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
7.5. Others
7.5.1. Others Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
Chapter 8. Product Risk Business Analysis
8.1. Non-Invasive Prenatal Testing Market: Product Movement Analysis
8.2. Consumables & Reagents
8.2.1. Consumables & Reagents Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
8.3. Instruments
8.3.1. Instruments Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
Chapter 9. Application Risk Business Analysis
9.1. Non-Invasive Prenatal Testing Market: Application Movement Analysis
9.2. TRISOMY
9.2.1. TRISOMY Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
9.3. Microdeletion Syndrome
9.3.1. Microdeletion Syndrome Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
9.4. Others
9.4.1. Others Non-Invasive Prenatal Testing Market, 2018 – 2030 (USD Million)
Chapter 10. End-use Business Analysis
10.1. Non-Invasive Prenatal Testing Market: End-Use Movement Analysis
10.2. Hospitals & Clinics
10.2.1. Hospitals & Clinics Market, 2018 – 2030 (USD Million)
10.3. Diagnostics Laboratories
10.3.1. Diagnostics Laboratories Companies Market, 2018 – 2030 (USD Million)
10.4. Academic and Research Institutes
10.4.1. Academic and Research Institutes Market, 2018 – 2030 (USD Million)
Chapter 11. Regional Business Analysis
11.1. Non-Invasive Prenatal Testing Market Share By Region, 2023 & 2030
11.2. North America
11.2.1. North America Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.2.2. U.S.
11.2.2.1. Key Country Dynamics
11.2.2.2. Target Disease Prevalence
11.2.2.3. Competitive Scenario
11.2.2.4. Regulatory Framework
11.2.2.5. Reimbursement Scenario
11.2.2.6. U.S. Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.2.3. Canada
11.2.3.1. Key Country Dynamics
11.2.3.2. Target Disease Prevalence
11.2.3.3. Competitive Scenario
11.2.3.4. Regulatory Framework
11.2.3.5. Reimbursement Scenario
11.2.3.6. Canada Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3. Europe
11.3.1. Europe Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.2. Germany
11.3.2.1. Key Country Dynamics
11.3.2.2. Target Disease Prevalence
11.3.2.3. Competitive Scenario
11.3.2.4. Regulatory Framework
11.3.2.5. Reimbursement Scenario
11.3.2.6. Germany Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.3. UK
11.3.3.1. Key Country Dynamics
11.3.3.2. Target Disease Prevalence
11.3.3.3. Competitive Scenario
11.3.3.4. Regulatory Framework
11.3.3.5. Reimbursement Scenario
11.3.3.6. UK Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.4. France
11.3.4.1. Key Country Dynamics
11.3.4.2. Target Disease Prevalence
11.3.4.3. Competitive Scenario
11.3.4.4. Regulatory Framework
11.3.4.5. Reimbursement Scenario
11.3.4.6. France Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.5. Italy
11.3.5.1. Key Country Dynamics
11.3.5.2. Target Disease Prevalence
11.3.5.3. Competitive Scenario
11.3.5.4. Regulatory Framework
11.3.5.5. Reimbursement Scenario
11.3.5.6. Italy Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.6. Spain
11.3.6.1. Key Country Dynamics
11.3.6.2. Target Disease Prevalence
11.3.6.3. Competitive Scenario
11.3.6.4. Regulatory Framework
11.3.6.5. Reimbursement Scenario
11.3.6.6. Spain Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.7. Denmark
11.3.7.1. Key Country Dynamics
11.3.7.2. Target Disease Prevalence
11.3.7.3. Competitive Scenario
11.3.7.4. Regulatory Framework
11.3.7.5. Reimbursement Scenario
11.3.7.6. Denmark Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.8. Sweden
11.3.8.1. Key Country Dynamics
11.3.8.2. Target Disease Prevalence
11.3.8.3. Competitive Scenario
11.3.8.4. Regulatory Framework
11.3.8.5. Reimbursement Scenario
11.3.8.6. Sweden Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.3.9. Norway
11.3.9.1. Key Country Dynamics
11.3.9.2. Target Disease Prevalence
11.3.9.3. Competitive Scenario
11.3.9.4. Regulatory Framework
11.3.9.5. Reimbursement Scenario
11.3.9.6. Norway Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4. Asia Pacific
11.4.1. Asia Pacific Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4.2. Japan
11.4.2.1. Key Country Dynamics
11.4.2.2. Target Disease Prevalence
11.4.2.3. Competitive Scenario
11.4.2.4. Regulatory Framework
11.4.2.5. Reimbursement Scenario
11.4.2.6. Japan Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4.3. China
11.4.3.1. Key Country Dynamics
11.4.3.2. Target Disease Prevalence
11.4.3.3. Competitive Scenario
11.4.3.4. Regulatory Framework
11.4.3.5. Reimbursement Scenario
11.4.3.6. China Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4.4. India
11.4.4.1. Key Country Dynamics
11.4.4.2. Target Disease Prevalence
11.4.4.3. Competitive Scenario
11.4.4.4. Regulatory Framework
11.4.4.5. Reimbursement Scenario
11.4.4.6. India Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4.5. South Korea
11.4.5.1. Key Country Dynamics
11.4.5.2. Target Disease Prevalence
11.4.5.3. Competitive Scenario
11.4.5.4. Regulatory Framework
11.4.5.5. Reimbursement Scenario
11.4.5.6. South Korea Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4.6. Australia
11.4.6.1. Key Country Dynamics
11.4.6.2. Target Disease Prevalence
11.4.6.3. Competitive Scenario
11.4.6.4. Regulatory Framework
11.4.6.5. Reimbursement Scenario
11.4.6.6. Australia Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.4.7. Thailand
11.4.7.1. Key Country Dynamics
11.4.7.2. Target Disease Prevalence
11.4.7.3. Competitive Scenario
11.4.7.4. Regulatory Framework
11.4.7.5. Reimbursement Scenario
11.4.7.6. Thailand Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.5. Latin America
11.5.1. Latin America Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.5.2. Brazil
11.5.2.1. Key Country Dynamics
11.5.2.2. Target Disease Prevalence
11.5.2.3. Competitive Scenario
11.5.2.4. Regulatory Framework
11.5.2.5. Reimbursement Scenario
11.5.2.6. Brazil Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.5.3. Mexico
11.5.3.1. Key Country Dynamics
11.5.3.2. Target Disease Prevalence
11.5.3.3. Competitive Scenario
11.5.3.4. Regulatory Framework
11.5.3.5. Reimbursement Scenario
11.5.3.6. Mexico Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.5.4. Argentina
11.5.4.1. Key Country Dynamics
11.5.4.2. Target Disease Prevalence
11.5.4.3. Competitive Scenario
11.5.4.4. Regulatory Framework
11.5.4.5. Reimbursement Scenario
11.5.4.6. Argentina Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.6. MEA
11.6.1. MEA Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.6.2. South Africa
11.6.2.1. Key Country Dynamics
11.6.2.2. Target Disease Prevalence
11.6.2.3. Competitive Scenario
11.6.2.4. Regulatory Framework
11.6.2.5. Reimbursement Scenario
11.6.2.6. South Africa Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.6.3. Saudi Arabia
11.6.3.1. Key Country Dynamics
11.6.3.2. Target Disease Prevalence
11.6.3.3. Competitive Scenario
11.6.3.4. Regulatory Framework
11.6.3.5. Reimbursement Scenario
11.6.3.6. Saudi Arabia Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.6.4. UAE
11.6.4.1. Key Country Dynamics
11.6.4.2. Target Disease Prevalence
11.6.4.3. Competitive Scenario
11.6.4.4. Regulatory Framework
11.6.4.5. Reimbursement Scenario
11.6.4.6. UAE Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
11.6.5. Kuwait
11.6.5.1. Key Country Dynamics
11.6.5.2. Target Disease Prevalence
11.6.5.3. Competitive Scenario
11.6.5.4. Regulatory Framework
11.6.5.5. Reimbursement Scenario
11.6.5.6. Kuwait Non-Invasive Prenatal Testing market, 2018 – 2030 (USD Million)
Chapter 12. Competitive Landscape
12.1. Participant’s overview
12.2. Financial performance
12.3. Participant categorization
12.3.1. Market Leaders
12.3.2. Non-Invasive Prenatal Testing market Share Analysis, 2023
12.3.3. Company Profiles
12.3.3.1. Genesis Genetics (CooperSurgical, Inc.)
12.3.3.1.1. Company Overview
12.3.3.1.2. Financial Performance
12.3.3.1.3. Product Benchmarking
12.3.3.1.4. Strategic Initiatives
12.3.3.2. Natera, Inc.
12.3.3.2.1. Company Overview
12.3.3.2.2. Financial Performance
12.3.3.2.3. Product Benchmarking
12.3.3.2.4. Strategic Initiatives
12.3.3.3. Centogene N.V.
12.3.3.3.1. Company Overview
12.3.3.3.2. Financial Performance
12.3.3.3.3. Product Benchmarking
12.3.3.3.4. Strategic Initiatives
12.3.3.4. Eurofins Scientific
12.3.3.4.1. Company Overview
12.3.3.4.2. Financial Performance
12.3.3.4.3. Product Benchmarking
12.3.3.4.4. Strategic Initiatives
12.3.3.5. MedGenome Labs Ltd.
12.3.3.5.1. Company Overview
12.3.3.5.2. Financial Performance
12.3.3.5.3. Product Benchmarking
12.3.3.5.4. Strategic Initiatives
12.3.3.6. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
12.3.3.6.1. Company Overview
12.3.3.6.2. Financial Performance
12.3.3.6.3. Product Benchmarking
12.3.3.6.4. Strategic Initiatives
12.3.3.7. Myriad Women’s Health, Inc. (Counsyl, Inc.)
12.3.3.7.1. Company Overview
12.3.3.7.2. Financial Performance
12.3.3.7.3. Product Benchmarking
12.3.3.7.4. Strategic Initiatives
12.3.3.8. Progenity, Inc.
12.3.3.8.1. Company Overview
12.3.3.8.2. Financial Performance
12.3.3.8.3. Product Benchmarking
12.3.3.8.4. Strategic Initiatives
12.3.3.9. Qiagen
12.3.3.9.1. Company Overview
12.3.3.9.2. Financial Performance
12.3.3.9.3. Product Benchmarking
12.3.3.9.4. Strategic Initiatives
12.3.3.10. Laboratory Corp. of America Holdings
12.3.3.10.1. Company Overview
12.3.3.10.2. Financial Performance
12.3.3.10.3. Product Benchmarking
12.3.3.10.4. Strategic Initiatives
12.3.3.11. Illumina, Inc. (Verinata Health, Inc.)
12.3.3.11.1. Company Overview
12.3.3.11.2. Financial Performance
12.3.3.11.3. Product Benchmarking
12.3.3.11.4. Strategic Initiatives
12.3.3.12. Quest Diagnostics, Inc.
12.3.3.12.1. Company Overview
12.3.3.12.2. Financial Performance
12.3.3.12.3. Product Benchmarking
12.3.3.12.4. Strategic Initiatives
12.3.4. Strategy Mapping
12.3.4.1. Expansion
12.3.4.2. Acquisition
12.3.4.3. Collaborations
12.3.4.4. Product Type/Product Launch
12.3.4.5. Partnerships
12.3.4.6. Others

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Regulatory framework
TABLE 4 Risk of Trisomy 21 and chromosomal abnormalities with maternal age
TABLE 5 Average selling prices of non-invasive prenatal tests
TABLE 6 North America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 7 North America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 8 North America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 9 North America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 10 North America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 11 North America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 12 North America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 13 North America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 14 U.S. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 15 U.S. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 16 U.S. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 17 U.S. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 18 U.S. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 19 U.S. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 20 U.S. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 21 Canada NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 22 Canada NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 23 Canada NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 24 Canada NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 25 Canada NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 26 Canada NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 27 Canada NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 28 Europe NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 29 Europe NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 30 Europe NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 31 Europe NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 32 Europe NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 33 Europe NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 34 Europe NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 35 Europe NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 36 U.K. NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 37 U.K. NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 38 U.K. NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 39 U.K. NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 40 U.K. NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 41 U.K. NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 42 U.K. NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 43 Germany NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 44 Germany NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 45 Germany NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 46 Germany NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 47 Germany NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 48 Germany NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 49 Germany NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 50 France NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 51 France NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 52 France NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 53 France NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 54 France NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 55 France NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 56 France NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 57 Italy NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 58 Italy NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 59 Italy NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 60 Italy NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 61 Italy NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 62 Italy NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 63 Italy NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 64 Spain NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 65 Spain NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 66 Spain NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 67 Spain NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 68 Spain NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 69 Spain NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 70 Spain NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 71 Denmark NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 72 Denmark NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 73 Denmark NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 74 Denmark NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 75 Denmark NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 76 Denmark NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 77 Denmark NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 78 Sweden NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 79 Sweden NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 80 Sweden NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 81 Sweden NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 82 Sweden NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 83 Sweden NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 84 Sweden NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 85 Norway NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 86 Norway NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 87 Norway NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 88 Norway NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 89 Norway NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 90 Norway NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 91 Norway NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 92 Asia Pacific NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 93 Asia Pacific NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 94 Asia Pacific NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 95 Asia Pacific NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 96 Asia Pacific NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 97 Asia Pacific NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 98 Asia Pacific NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 99 Asia Pacific NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 100 Japan NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 101 Japan NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 102 Japan NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 103 Japan NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 104 Japan NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 105 Japan NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 106 Japan NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 107 China NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 108 China NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 109 China NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 110 China NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 111 China NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 112 China NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 113 China NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 114 India NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 115 India NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 116 India NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 117 India NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 118 India NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 119 India NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 120 India NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 121 South Korea NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 122 South Korea NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 123 South Korea NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 124 South Korea NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 125 South Korea NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 126 South Korea NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 127 South Korea NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 128 Australia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 129 Australia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 130 Australia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 131 Australia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 132 Australia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 133 Australia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 134 Australia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 135 Thailand NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 136 Thailand NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 137 Thailand NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 138 Thailand NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 139 Thailand NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 140 Thailand NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 141 Thailand NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 142 Latin America NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 143 Latin America NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 144 Latin America NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 145 Latin America NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 146 Latin America NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 147 Latin America NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 148 Latin America NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 149 Latin America NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 150 Brazil NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 151 Brazil NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 152 Brazil NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 153 Brazil NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 154 Brazil NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 155 Brazil NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 156 Brazil NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 157 Mexico NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 158 Mexico NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 159 Mexico NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 160 Mexico NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 161 Mexico NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 162 Mexico NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 163 Mexico NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 164 Argentina NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 165 Argentina NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 166 Argentina NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 167 Argentina NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 168 Argentina NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 169 Argentina NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 170 Argentina NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 171 MEA NIPT market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 172 MEA NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 173 MEA NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 174 MEA NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 175 MEA NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 176 MEA NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 177 MEA NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 178 MEA NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 179 South Africa NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 180 South Africa NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 181 South Africa NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 182 South Africa NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 183 South Africa NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 184 South Africa NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 185 South Africa NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 186 Saudi Arabia NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 187 Saudi Arabia NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 188 Saudi Arabia NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 189 Saudi Arabia NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 190 Saudi Arabia NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 191 Saudi Arabia NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 192 Saudi Arabia NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 193 UAE NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 194 UAE NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 195 UAE NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 196 UAE NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 197 UAE NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 198 UAE NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 199 UAE NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 200 Kuwait NIPT market estimates and forecasts, by gestation period, 2018 - 2030 (USD Million)
TABLE 201 Kuwait NIPT market estimates and forecasts, by pregnancy risk, 2018 - 2030 (USD Million)
TABLE 202 Kuwait NIPT market estimates and forecasts, by method, 2018 - 2030 (USD Million)
TABLE 203 Kuwait NIPT market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 204 Kuwait NIPT market estimates and forecasts, by product, 2018 - 2030 (USD Million)
TABLE 205 Kuwait NIPT market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 206 Kuwait NIPT market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

※본 조사보고서 [세계의 비침습적 산전 검사 (NIPT) 시장 (2024-2030) : 임신 기간별, 임신 위험별, 방법별, 기술별, 제품별, 용도별, 최종 용도별, 지역별] (코드 : GRV24JNU068) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 비침습적 산전 검사 (NIPT) 시장 (2024-2030) : 임신 기간별, 임신 위험별, 방법별, 기술별, 제품별, 용도별, 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

글로벌 치과용 3D 프린팅 시장 (2024-2030) : 교정, 보철, 임플란트
GRV24JAN098 / Grand View Research / 2023년 11월 / 글로벌 치과용 3D 프린팅 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 치과용 3D 프린팅 시장 규모는 2030년까지 159억 달러에 달할 것으로 예측됩니다. 이 시장은 2024년부터 2030년까지...1. 조사 방법 및 범위 2. 개요 3. 세계의 치과용 3D 프린팅 시장 변수/동향/범위 4. 세계의 치과용 3D 프린팅 시장 규모 : 용도별 예측 및 동향 분석 5. 세계의 치과용 3D 프린팅 시장 규모 : 기술별 예측 및 동향 분석 6. 세계의 치과용 3D 프린팅 시장 규모 : 최종 용도별...

글로벌 스마트 알약 시장 (2023-2030) : 제품, 도구, 환자 모니터링 소프트웨어
GRV24JAN167 / Grand View Research / 2023년 11월 / 글로벌 스마트 알약 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 스마트 알약 시장 규모는 2030년까지 40억 9000만 달러에 달할 것으로 예상되며, 예측 기간 동안 11.4%의 CAGR을...1. 조사 방법 및 범위 2. 개요 3. 세계의 스마트 알약 시장 변수/동향/범위 4. 세계의 스마트 알약 시장 규모 : 용도별 예측 및 동향 분석 5. 세계의 스마트 알약 시장 규모 : 지역별 예측 및 동향 분석 6. 경쟁 현황...

글로벌 갱년기 치료 시장 (2024-2030) : 식이 보조제, OTC 의약품
GRV24JAN121 / Grand View Research / 2023년 11월 / 글로벌 갱년기 치료 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 갱년기 치료 시장 규모는 2024년부터 2030년까지 연평균 5.37%의 성장률을 기록하며 2030년까지 244억 달러에 달할 것으로 예상됩니다....1. 조사 방법 및 범위 2. 개요 3. 세계의 갱년기 치료 시장 변수/동향/범위 4. 세계의 갱년기 치료 시장 규모 : 치료별 비즈니스 분석 5. 세계의 갱년기 치료 시장 규모 : 지역별 비즈니스 분석 6. 경쟁 현황...

글로벌 보툴리눔톡신 (보톡스) 시장 (2024-2030) : 유형 A, 유형 B
GRV24JAN093 / Grand View Research / 2023년 11월 / 글로벌 보툴리눔톡신 (보톡스) 시장의 성장과 동향 Grand View Research, Inc.사의 새로운 보고서에 따르면, 세계의 보툴리눔톡신 (보톡스) 시장 규모는 2030년까지 211억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 9.8%의 CAGR을 기록할 것으로...1. 조사 방법 및 범위 2. 개요 3. 세계의 보툴리눔톡신 (보톡스) 시장 규모 : 변수, 동향 및 범위 4. 세계의 보툴리눔톡신 (보톡스) 시장 규모 : 제품 유형별 세분 분석 5. 세계의 보툴리눔톡신 (보톡스) 시장 규모 : 용도별 세그먼트 분석 6. 세계의 보툴리눔톡신 (보톡스) 시장 규모 : 최종 용도별 세그먼트 분석...

세계의 칼슘 하이드록실아파타이트 (CaHA) 필러 시장 (2024-2030) : 용도별 (얼굴 주름 및 주름, 턱 윤곽, 지방 위축), 최종 용도별 (메드 스파, 성형 외과, 병원)
GRV24JNU082 / Grand View Research / 2023년 12월 / 글로벌 칼슘 하이드록실아파타이트 (CaHA) 필러 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 칼슘 하이드록실아파타이트 (CaHA) 필러 시장은 2030년까지 16억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 13.8%의...1. 조사 방법 및 범위 2. 개요 3. 세계의 칼슘 하이드록실아파타이트 (CaHA) 필러 시장 변수, 동향 및 범위 4. 세계의 칼슘 하이드록실아파타이트 (CaHA) 필러 시장 규모 : 용도별 예측 및 동향 분석 5. 세계의 칼슘 하이드록실아파타이트 (CaHA) 필러 시장 규모 : 최종 용도별 예측 및 동향 분석 6. 세계의 칼슘...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!